In 2016, the US Drug Enforcement Administration said it would, for the first time, open applications for those hoping to become federally-licensed cannabis researchers. The details came four years later.
Cannabis Wire spoke with the CDC’s National Institute for Occupational Safety and Health about the emerging cannabis industry and its workers.
Research from Penn State looks at Denver, Colorado and suggests that legalization is, at worst, neutral, but likely positive for hospitality.
In a Q&A, the founder of one of the companies hoping for a federal license to supply researchers shares the frustrations of the process.
“I think the increases are mainly driven by boomers who use weed aging into the 65 and older age bracket,” the study’s senior author told Cannabis Wire.
Among the more than thirty applicants with the Drug Enforcement Administration are big names, from Canopy Growth to Battelle.
A regulatory standards expert describes a patchwork system, the need for consistent rules to protect consumers, and the need for research to properly set those rules.
The CDC on Friday confirmed a decline in reports of vaping-related lung illnesses.
A new brewing process could not only be more cost-effective than cannabis cultivation, but could allow scientists to access possibly beneficial compounds that are present at lower levels in the plant.
“This will meet the need created by the increase in the amount of approved research involving marijuana,” the DEA told Cannabis Wire.
The ACS now has more than 300 members focused on researching cannabis, but there may be a need for more expansion.
Is the DEA Opening a Door to Cannabis Cultivation for Research? Or Is It Continuing to Drag Its Feet?
The agency says it will respond to pending applications, but first it will propose new regulations—without a timeline.
A university researcher needs veterans as subjects for his work on PTSD. He says the VA is making recruitment difficult.
A recent cannabis and opioid study highlighted that “corporate actors” with “deep pockets have substantial ability to promote congenial results, as suffering people are desperate for effective solutions.”
Q&A: After a survey shows a hunger for answers among clinicians and patients alike, a foundation gathers experts to chart a research path. Here’s why.